Healthcare Press Micronesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Micronesia.

Press releases published on August 31, 2026

2 hours ago

BioVie Announces Completion of Treatment Phase of ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

Indeterminate GlobeNewswire

2 hours ago

Revelyx Bio Launches to Advance YY003, an Investigational Recombinant Botulinum Toxin Type A in a Ready-to-Use Liquid Formulation

Indeterminate GlobeNewswire

2 hours ago

ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib

Indeterminate GlobeNewswire

2 hours ago

Teladoc Health Appoints Michael Grasher as Chief Financial Officer

Indeterminate GlobeNewswire

2 hours ago

Chemomab Therapeutics to Present at H.C. Wainwright 28th Annual Global Investor Conference

Indeterminate GlobeNewswire

2 hours ago

Alpha Tau Completes Patient Enrollment in its Multicenter IMPACT Pancreatic Cancer Pilot Study of Alpha DaRT® Following Strong Demand and Multiple Expansions

Indeterminate GlobeNewswire

2 hours ago

Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray

Indeterminate GlobeNewswire

2 hours ago

Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day

Indeterminate GlobeNewswire

2 hours ago

NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

SRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers

Indeterminate GlobeNewswire

2 hours ago

Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Indeterminate GlobeNewswire

3 hours ago

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

Indeterminate GlobeNewswire

3 hours ago

Ascendis and BioMarin Enter Binding Term Sheet for a Global Settlement and License Agreement Related to YUVIWEL® (Navepegritide)

Indeterminate GlobeNewswire

3 hours ago

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

Indeterminate GlobeNewswire

3 hours ago

Global Markets for Fermentation Ingredients to Reach $53.4 Billion by 2031, Driven by Rising Demand for Animal Nutrition Ingredients

Indeterminate GlobeNewswire

3 hours ago

Global Markets and Technologies for Electronic Health Records to Reach $52.2 Billion by 2030, Driven by Rising Chronic Disease Burden and Digital Health Adoption

Indeterminate GlobeNewswire

5 hours ago

Medera Presents Late-Breaking Clinical Trial Data at ESC Congress 2026 Demonstrating Durable Improvement in HFpEF Cardiac Filling Pressures Following SRD-002 Gene Therapy

Indeterminate GlobeNewswire

5 hours ago

Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

Indeterminate GlobeNewswire

6 hours ago

XYRA Announces First Patient Dosed in Europe in the Phase 2/3 HARBOR-AF Study of Budiodarone in Paroxysmal and Persistent Atrial Fibrillation

Indeterminate GlobeNewswire

6 hours ago

AI Disruption in Electronic Health Records Accelerates as Venture Capital Inflows Surpass $1 Billion in 2025

Indeterminate GlobeNewswire